ABD Dermatopathology common mistakes
ABD Dermatopathology · Understand the traps and how to avoid them.
Reading a vacuolar interface dermatitis as lichen planus without documenting features that favor lupus erythematosus (dermal mucin, periadnexal lymphocytic infiltrate, plasma cells, follicular involvement) and without requesting direct immunofluorescence when lupus is in the differential.
Lichenoid and interface patterns overlap heavily on H&E, and anchoring on the most familiar diagnosis short-circuits the systematic search for subtle lupus-defining features; busy sign-out also discourages ordering DIF once a 'satisfying' label is reached.
What to do instead
Use a fixed interface-dermatitis checklist on every case (degree of vacuolar change, mucin, periadnexal/perifollicular infiltrate, plasma cells, eosinophils, keratinocyte necrosis, lichenoid vs. vacuolar predominance) and order DIF whenever lupus or a bullous disorder remains possible; state the checklist findings in the report.
Diagnosing a subepidermal blister as bullous pemphigoid or dermatitis herpetiformis on H&E alone and signing out without direct immunofluorescence and, where indicated, salt-split-skin mapping.
Subepidermal blisters with mixed inflammation are notoriously non-specific on H&E, and candidates often treat DIF as optional confirmatory testing rather than the diagnostic gold standard.
What to do instead
Make DIF mandatory for every new subepidermal or pauci-inflammatory blister; interpret linear vs. granular deposition of IgG, IgA, C3, and fibrinogen, and use salt-split skin (or antigen-specific serology) to separate BP from EBA and DH when the pattern is linear.
Measuring Breslow thickness through deep adnexal extension, or from the base of an ulcer rather than applying the correct AJCC measurement rules, and reporting a single depth without documenting the measurement landmarks.
Melanoma can extend down hair follicles or eccrine ducts, and the AJCC convention excludes periadnexal extension from Breslow thickness; candidates either forget this exception or measure from the ulcer base incorrectly.
What to do instead
Measure Breslow from the granular layer (or from the base of the ulcer when ulcerated) to the deepest contiguous invasive melanoma cell, explicitly excluding periadnexal/perivascular extension; document the measurement landmarks and the deepest level in the report.
Calling a hypocellular dermal spindle cell proliferation in sun-damaged skin a scar or benign fibrous lesion without deeper levels, without documenting perineural invasion, and without SOX10 or S100.
Desmoplastic melanoma is paucicellular, scar-like, and often lacks an obvious junctional component, so it is easily dismissed as reactive fibrosis; immunohistochemistry is frequently omitted because the H&E looks bland.
What to do instead
For any scar-like dermal spindle cell proliferation in chronically sun-damaged skin, obtain deeper levels, search for perineural invasion and lymphoid aggregates, and order SOX10 (with S100 and p16 as needed); if negative, state the stain results and recommend re-excision or close follow-up when clinical suspicion persists.
Signing out a sclerosing adnexal proliferation as a benign adnexal tumor without evaluating perineural invasion and without a panel including p63, CK20, EMA, and CEA.
Microcystic adnexal carcinoma and desmoplastic trichoepithelioma can both show bland cords in sclerotic stroma; the malignant diagnosis hinges on perineural invasion and deep infiltration, which are easy to miss on a superficial or tangentially oriented biopsy.
What to do instead
For sclerosing adnexal tumors, systematically search for perineural invasion and deep subcutaneous/fatty infiltration, and use p63/CK20/EMA/CEA to define the line of differentiation; if the biopsy is superficial and the architecture is ambiguous, report the uncertainty and recommend re-excision with margin assessment.
Diagnosing a sebaceous adenoma as a sporadic benign lesion without ordering mismatch repair immunohistochemistry in a patient with multiple sebaceous neoplasms, young age, or a personal/family history suggesting Muir-Torre syndrome.
Sebaceous adenomas are common and usually sporadic, and candidates often treat MMR testing as a clinical afterthought rather than a pathology-driven screen; the histologic distinction from sebaceous hyperplasia or carcinoma also consumes attention.
What to do instead
Apply a low threshold for MMR IHC (MLH1, PMS2, MSH2, MSH6) in any sebaceous adenoma/epithelioma with clinical red flags or multiple lesions; document the indication and communicate the result so germline testing and colonoscopy can be arranged.
Diagnosing cutaneous lymphoma on a dense mixed dermal infiltrate without checking Bcl-2, CD10, Bcl-6, CD3/CD20/CD30, and clonality studies, and without correlating with the clinical distribution and duration.
Pseudolymphomas can show germinal centers, numerous B cells, and even monoclonal-appearing peaks, while some lymphomas are bland; pattern recognition alone without an IHC/clonality panel leads to both over- and underdiagnosis.
What to do instead
For dense lymphoid infiltrates, characterize the architecture (top-heavy vs. bottom-heavy, grenz zone, epidermotropism), run a B- and T-cell panel including Bcl-2, CD10, Bcl-6, CD21/CD23, CD30, and CD4/CD8, and add TCR/Ig gene rearrangement when the phenotype is ambiguous; integrate the result with clinical stage and history before signing out.
Missing leukemia cutis because the infiltrate is sparse and perivascular, dismissing it as perivascular dermatitis without checking for atypical mononuclear cells and without MPO, CD117, CD34, CD68, or CD163.
Leukemia cutis can be subtle, interstitial, and perivascular, mimicking a reactive dermatitis; the cells may not look overtly malignant on H&E, and myeloid markers are not part of the routine dermatitis panel.
What to do instead
In any atypical perivascular/interstitial mononuclear infiltrate with clinical concern for leukemia or an unexplained blood count abnormality, examine high-power morphology for atypical cells and add MPO, CD117, CD34, CD68, CD163, and CD56 as appropriate; correlate with the peripheral smear and bone marrow findings.
Overdiagnosing angiosarcoma in a bland vascular proliferation on sun-damaged skin without assessing dissecting vascular channels, endothelial atypia, and without ERG or CD31 to confirm endothelial lineage.
Sun-damaged skin frequently shows atypical vascular proliferations (e.g., hobnail hemangioma, reactive angioendotheliomatosis, or radiation-associated atypical vascular lesions), and the fear of missing angiosarcoma pushes candidates toward malignancy without applying strict criteria.
What to do instead
Require a combination of dissecting channels, endothelial atypia, multilayering, and infiltrative growth before diagnosing angiosarcoma; confirm endothelial lineage with ERG/CD31/CD34, assess Ki-67, and obtain clinical context (radiation, lymphedema, prior surgery) before final classification.
Failing to identify perineural invasion in a spindle cell tumor or misclassifying a neurofibroma as MPNST (or vice versa) without SOX10, S100, and p16, and without documenting the nerve involvement in the report.
Perineural invasion is easily overlooked at low power, and benign neural tumors can show atypia while low-grade MPNST can be deceptively bland; candidates often rely on H&E alone and do not systematically trace nerves at the periphery.
What to do instead
For any spindle cell or neural tumor, scan the periphery and deep margin for nerves with perineural invasion, document its presence and size, and use SOX10/S100 with p16 and Ki-67 to support MPNST when morphology is worrisome; state the limitations if the biopsy is superficial.